317 related articles for article (PubMed ID: 9284947)
1. Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes.
Montrose-Rafizadeh C; Yang H; Wang Y; Roth J; Montrose MH; Adams LG
J Cell Physiol; 1997 Sep; 172(3):275-83. PubMed ID: 9284947
[TBL] [Abstract][Full Text] [Related]
2. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
Göke R; Fehmann HC; Linn T; Schmidt H; Krause M; Eng J; Göke B
J Biol Chem; 1993 Sep; 268(26):19650-5. PubMed ID: 8396143
[TBL] [Abstract][Full Text] [Related]
3. Lipolytic action of glucagon-like peptides in isolated rat adipocytes.
Ruiz-Grande C; Alarcón C; Mérida E; Valverde I
Peptides; 1992; 13(1):13-6. PubMed ID: 1320261
[TBL] [Abstract][Full Text] [Related]
4. High potency antagonists of the pancreatic glucagon-like peptide-1 receptor.
Montrose-Rafizadeh C; Yang H; Rodgers BD; Beday A; Pritchette LA; Eng J
J Biol Chem; 1997 Aug; 272(34):21201-6. PubMed ID: 9261127
[TBL] [Abstract][Full Text] [Related]
5. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells.
Moens K; Heimberg H; Flamez D; Huypens P; Quartier E; Ling Z; Pipeleers D; Gremlich S; Thorens B; Schuit F
Diabetes; 1996 Feb; 45(2):257-61. PubMed ID: 8549871
[TBL] [Abstract][Full Text] [Related]
6. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
[TBL] [Abstract][Full Text] [Related]
7. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
Kolligs F; Fehmann HC; Göke R; Göke B
Diabetes; 1995 Jan; 44(1):16-9. PubMed ID: 7813808
[TBL] [Abstract][Full Text] [Related]
8. Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells.
Gallwitz B; Witt M; Fölsch UR; Creutzfeldt W; Schmidt WE
J Mol Endocrinol; 1993 Jun; 10(3):259-68. PubMed ID: 8396943
[TBL] [Abstract][Full Text] [Related]
9. Stable expression of the rat GLP-I receptor in CHO cells: activation and binding characteristics utilizing GLP-I(7-36)-amide, oxyntomodulin, exendin-4, and exendin(9-39).
Fehmann HC; Jiang J; Schweinfurth J; Wheeler MB; Boyd AE; Göke B
Peptides; 1994; 15(3):453-6. PubMed ID: 7937318
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
[TBL] [Abstract][Full Text] [Related]
11. Dual glucagon recognition by pancreatic beta-cells via glucagon and glucagon-like peptide 1 receptors.
Moens K; Flamez D; Van Schravendijk C; Ling Z; Pipeleers D; Schuit F
Diabetes; 1998 Jan; 47(1):66-72. PubMed ID: 9421376
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1(7-36) amide (GLP-1) enhances insulin-stimulated glucose metabolism in 3T3-L1 adipocytes: one of several potential extrapancreatic sites of GLP-1 action.
Egan JM; Montrose-Rafizadeh C; Wang Y; Bernier M; Roth J
Endocrinology; 1994 Nov; 135(5):2070-5. PubMed ID: 7956929
[TBL] [Abstract][Full Text] [Related]
13. The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I(7-37).
Lu M; Wheeler MB; Leng XH; Boyd AE
Endocrinology; 1993 Jan; 132(1):94-100. PubMed ID: 8380389
[TBL] [Abstract][Full Text] [Related]
14. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
15. Regulation of glucose transporters and hexose uptake in 3T3-L1 adipocytes: glucagon-like peptide-1 and insulin interactions.
Wang Y; Kole HK; Montrose-Rafizadeh C; Perfetti R; Bernier M; Egan JM
J Mol Endocrinol; 1997 Dec; 19(3):241-8. PubMed ID: 9460645
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M
Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1(7-36)amide enhances insulin-stimulated glucose uptake and decreases intracellular cAMP content in isolated rat adipocytes.
Miki H; Namba M; Nishimura T; Mineo I; Matsumura T; Miyagawa J; Nakajima H; Kuwajima M; Hanafusa T; Matsuzawa Y
Biochim Biophys Acta; 1996 Jun; 1312(2):132-6. PubMed ID: 8672535
[TBL] [Abstract][Full Text] [Related]
18. GLP-1 receptor agonist increases the expression of CTRP3, a novel adipokine, in 3T3-L1 adipocytes through PKA signal pathway.
Li X; Jiang L; Yang M; Wu Y; Sun S; Sun J
J Endocrinol Invest; 2015 Jan; 38(1):73-9. PubMed ID: 25149084
[TBL] [Abstract][Full Text] [Related]
19. Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats.
Sancho V; Trigo MV; González N; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML
J Mol Endocrinol; 2005 Aug; 35(1):27-38. PubMed ID: 16087719
[TBL] [Abstract][Full Text] [Related]
20. GLP-1 amplifies insulin signaling by up-regulation of IRbeta, IRS-1 and Glut4 in 3T3-L1 adipocytes.
Gao H; Wang X; Zhang Z; Yang Y; Yang J; Li X; Ning G
Endocrine; 2007 Aug; 32(1):90-5. PubMed ID: 17992607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
